A novel serine protease SNC19 associated with human colorectal cancer

Objective To study the structure and function of a novel serine protease gene associated with human colorectal cancer SNC19 Methods The cDNA sequence was determined by both manual and automatic sequencing techniques The full length cDNA sequence was obtained by the 5' Rapid Amplification of cDNA Ends technique and web based analysis Open reading frame analysis and protein function prediction were also performed Northern blot was used to detect the expression of SNC19 in various human normal tissues and tumor cell lines Fluorescent in situ hybridization combined with fluorescent R banding technique was employed to map the SNC19 gene on human chromosome Results Full length SNC19 cDNA, size 3152 bp, encodes a protein highly homologous to a mouse serine protease epithin In normal human tissues, high SNC19 expression levels were observed in the kidney, pancreas, prostate, small intestine and colon; moderate SNC19 expression levels were observed in the placenta, lung, liver, spleen thymus, testis and peripheral blood lymphocytes; and extremely low expression levels were observed in the heart, brain, skeletal muscle and ovary In tumor cell lines, colorectal cancer cells SW480, SW620, SW1116 and Colo205, breast cancer cell Bcap37 and gastric cancer cells MKN28 and SGC7901 showed high levels of SNC19 expression; cervical cancer cell HeLa S3, lung cancer PAA, oral epithelial cancer cell KB and lymphoma cell Raji showed moderate levels of SNC19 expression; and tongue squamous cancer cell Tca8113, leukemia cells HL 60, K562, MOLT 4, lung cancer cell A549 and melanoma cell G361 showed very low levels of SNC19 expression SNC19 was mapped to human chromosome 11q24 25 Conclusion SNC19 encodes a novel human serine protease with 855 amino acid residues As a novel serine protease associated with human colorectal cancer, the expression of SNC19 in various tissues and cell lines may have very important impact on their phenotypes and biological behaviors